|
⚲
|
| Casdin Capital LLC
✚
|
|
|---|---|
| CRD # | 169579 |
| SEC # | 801-110894 |
| CIK # | 0001534261 |
| AUM | $2.7 BB (2023-03-31) |
| Employees | 38 (34% Investors, 0% Brokers) |
| Phone | 212-897-5430 |
| Address | 1350 Avenue of The Americas New York, NY 10019 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] |
| Total AUM ($BB) |
|---|
| CIK | Period |
|---|---|
| 0001534261 | |
| / | |
| Sector | Form 13F Holdings | Cap ($BB) | Value ($BB) |
|---|---|---|---|
| Biolife Solutions Inc | 0.6 | 0.2 | |
| Avi Biopharma Inc | 6.5 | 0.2 | |
| Relay Therapeutics Inc | 1.8 | 0.1 | |
| CM Life Sciences III Inc | 2.2 | 0.1 | |
| Illumina Inc | 29.4 | 0.1 | |
| Alnylam Pharmaceuticals Inc | 17.2 | 0.1 | |
| Intellia Therapeutics Inc | 3.9 | 0.0 | |
| Pliant Therapeutics Inc | 0.3 | 0.0 | |
| Revolution Medicines Inc | 1.3 | 0.0 | |
| Exact Sciences Corp | 7.2 | 0.0 | |
| CM Life Sciences II Inc | 0.9 | 0.0 | |
| Verve Therapeutics Inc | 0.8 | 0.0 | |
| Blueprint Medicines Corp | 3.2 | 0.0 | |
| Denali Therapeutics Inc | 3.6 | 0.0 | |
| Maxcyte Inc | 0.5 | 0.0 | |
| 2Seventy Bio Inc | 0.5 | 0.0 | |
| Abcellera Biologics Inc | 2.9 | 0.0 | |
| Mirati Therapeutics Inc | 3.8 | 0.0 | |
| 4D Molecular Therapeutics Inc | 0.2 | 0.0 | |
| Beam Therapeutics Inc | 2.8 | 0.0 | |
| Tenaya Therapeutics Inc | 0.2 | 0.0 | |
| Prometheus Biosciences Inc | 1.1 | 0.0 | |
| Avidity Biosciences Inc | 0.7 | 0.0 | |
| Fate Therapeutics Inc | 2.4 | 0.0 | |
| Century Therapeutics Inc | 0.5 | 0.0 | |
| Twist Bioscience Corp | 2.0 | 0.0 | |
| Absci Corp | 0.3 | 0.0 | |
| Prev | Page 1 | Next | |||
| Type | Form D Funds | Date | Sold ($MM) | AUM ($MM) |
|---|---|---|---|---|
| HF | Casdin Amplify Fund LP | 2022-11-22 | 19.1 | |
| HF | Casdin Partners FO1 - MSV LP | 2022-11-22 | 53.3 | |
| PE | Casdin Private Growth Equity Fund II LP | [2022-02-16] | 233.6 | 361.8 |
| PE | Casdin Private Growth Equity Fund LP | 2021-02-25 | 246.6 | |
| VC | Casdin Venture Opportunities Fund LP | [2018-03-28] | 30.0 | 28.4 |
| HF | Casdin Partners Master Fund LP | [2013-11-20] | 951.9 | 1,996.4 |
| AUM Breakdown | Accounts | AUM ($BB) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 2.7 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 2.7 |
| By Discretionary | ||
| Discretionary | 8 | 2.7 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 2.7 |
| By Non-United States Persons | ||
| Non-United States Persons | 2.0 | |
| United States Persons | 0.7 | |
| Total | 8 | 2.7 |
| Form D Directors | # Filings | # Firms | 2011 - 2023 |
|---|---|---|---|
| Eli Casdin | 18 | ||
| Casdin Capital LLC | 5 | ||
| Casdin Venture Opportunities Fund GP LLC | 1 | ||
| Casdin Private Growth Equity Fund II GP LLC | 1 | ||
| Casdin Partners GP LLC | 1 |
| EDGAR Form | CIK | 2011 - 2023 |
|---|---|---|
| 13F-HR | [0001534261] | |
| 3 | [0001534261] | |
| 4 | [0001534261] | |
| SC 13D | [0001534261] | |
| SC 13G | [0001534261] |
| Comparable Firms | State | AUM ($BB) |
|---|---|---|
|
P Schoenfeld Asset Management LP
✚
|
NY | 2.9 |
|
Hines Capital Advisors LLC
✚
|
TX | 2.9 |
|
Steadview Capital Management LLC
✚
|
2.8 | |
|
Blackstone Ireland Fund Management Limited
✚
|
2.7 | |
|
GS Investment Strategies LLC
✚
|
NY | 2.7 |
|
RCF Management LLC
✚
|
CO | 2.7 |
|
Inclusive Capital Partners LP
✚
|
CA | 2.7 |
|
Polychain Capital LP
✚
|
CA | 2.6 |
|
Marblegate Asset Management LLC
✚
|
CT | 2.5 |
|
XN LP
✚
|
NY | 2.5 |